Literature DB >> 8414830

Hepatitis B virus infection in Honolulu students.

E W Pon1, H Ren, H Margolis, Z Zhao, G C Schatz, A Diwan.   

Abstract

OBJECTIVES: To determine hepatitis B virus (HBV) carrier and infection rates and HBV epidemiology in Honolulu students.
DESIGN: Cross-sectional survey.
SETTING: Honolulu public elementary, intermediate, and high schools. PATIENTS: A volunteer sample of 4936 students from 43 Honolulu schools. MAIN OUTCOME MEASURES: HBV carrier rate (presence of hepatitis B surface antigen) and infection rate (presence of either hepatitis B surface antigen, antibody to hepatitis B surface antigen, antibody to hepatitis B core antigen, or any combinations of these) by school grade, ethnicity, and place of birth.
RESULTS: Eighty-three (1.68%) students were identified as HBV carriers, and a total of 353 (7.15%) students had serologic evidence of infection. Infection rates increased from elementary school age to high school age, more so in Asian/Pacific Island-born students. The prevalence of infection was higher in Asian/Pacific Island-born students than in those born in the United States. The majority of infected Hawaiian-born students were first-generation Asian/Pacific Island Americans.
CONCLUSIONS: Horizontal transmission of HBV occurs in Honolulu school-age children. HBV immunization of all infants in Hawaii, not just those born to carrier mothers, is necessary to reduce HBV transmission in Hawaii.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8414830

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  2 in total

1.  Genotype and phylogenetic characterization of hepatitis B virus among multi-ethnic cohort in Hawaii.

Authors:  Mayumi Sakurai; Fuminaka Sugauchi; Naoky Tsai; Seiji Suzuki; Izumi Hasegawa; Kei Fujiwara; Etsuro Orito; Ryuzo Ueda; Masashi Mizokami
Journal:  World J Gastroenterol       Date:  2004-08-01       Impact factor: 5.742

2.  Survival and hepatitis status among Asian Americans with hepatocellular carcinoma treated without liver transplantation.

Authors:  Jessica P Hwang; Manal M Hassan
Journal:  BMC Cancer       Date:  2009-02-04       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.